Metropolitan Life Insurance CO 23and Me Holding Co. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.4 - $0.91 $6,170 - $14,037	-15,426 Reduced 83.64%	3,018 $1,000
Q4 2023 Feb 14, 2024	BUY	$0.71 - $0.97 $2,863 - $3,912	4,033 Added 27.99%	18,444 $16,000
Q1 2023 May 15, 2023	SELL	$2.05 - $2.87 $3,991 - $5,587	-1,947 Reduced 11.9%	14,411 $32,000
Q4 2022 Jun 14, 2023	BUY	$2.06 - $3.47 $4,010 - $6,756	1,947 Added 13.51%	16,358 $35.3 Million
Q3 2022 Jun 14, 2023	BUY	$2.6 - $5.12 $5,062 - $9,968	1,947 Added 13.51%	16,358 $46.8 Million
Q3 2022 Mar 30, 2023	BUY	$2.6 - $5.12 $13,546 - $26,675	5,210 Added 46.73%	16,358 $46,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.12 $13,546 - $26,675	5,210 Added 46.73%	16,358 $47,000
Q2 2022 Jun 20, 2023	SELL	$2.19 - $3.98 $7,145 - $12,986	-3,263 Reduced 22.64%	11,148 $27,000
Q2 2022 Mar 30, 2023	SELL	$2.19 - $3.98 $11,409 - $20,735	-5,210 Reduced 31.85%	11,148 $27,000
Q2 2022 Aug 11, 2022	BUY	$2.19 - $3.98 $24,414 - $44,369	11,148 New	11,148 $28,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $849M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.